KIGS, KIMS and ACROSTUDY are important tools within modern evidence based medicine and support physicians in optimizing the treatment of individual patients as well as contribute to a wider understanding of growth hormone and Somavert® treatment.
KIGS, KIMS and ACROSTUDY are managed by Strategic Advisory Boards, whose members are elected from the pool of participating physicians. Data are regularly analyzed and the results published in peer-reviewed medical journals and reports.